Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Firebrick Pharma Limited ( (AU:FRE) ) has issued an announcement.
Firebrick Pharma Limited has successfully launched its Nasodine Nasal Spray in Singapore, expanding its availability to 125 Guardian pharmacies and gaining support from local doctors. The company also reported significant growth in online sales in the US, driven by marketing strategies and promotions, indicating strong market adoption and positioning for future growth.
More about Firebrick Pharma Limited
Firebrick Pharma Limited operates in the pharmaceutical industry, focusing on the development and distribution of innovative healthcare products. Their primary product is Nasodine Nasal Spray, a povidone-iodine nasal spray, which targets retail and medical markets.
YTD Price Performance: 33.33%
Average Trading Volume: 199,474
Technical Sentiment Signal: Sell
See more data about FRE stock on TipRanks’ Stock Analysis page.